| |
| |
| Exchange: |
OTC Bulletin Board |
| Security
Type: |
Common |
| Shares
Out: |
41,560,000 |
| Market
Cap: |
248.53(M) |
| Last
Volume: |
5,200 |
Avg
Vol: |
5,186 |
| 52
Week Range: |
$3.61 - $10.69 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Axogen is focused on the science, development and commercialization of technologies for peripheral nerve regeneration and repair. Co.'s platform for peripheral nerve repair features a portfolio of products, including Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed peripheral nerves without the comorbidities associated with a second surgical site; and Axoguard Nerve Connector, a porcine submucosa extracellular matrix coaptation aid for tensionless repair of severed peripheral nerves. Co. also provides Axotouch Two-Point Discriminator, which is used to measure the innervation density of any surface area of the skin.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
30,000 |
30,000 |
| Total Buy Value |
$0 |
$0 |
$188,940 |
$188,940 |
| Total People Bought |
0 |
0 |
3 |
3 |
| Total Buy Transactions |
0 |
0 |
3 |
3 |
| Total Shares Sold |
118,082 |
130,582 |
180,030 |
368,410 |
| Total Sell Value |
$980,899 |
$1,074,708 |
$1,509,387 |
$3,484,755 |
| Total People Sold |
5 |
6 |
6 |
6 |
| Total Sell Transactions |
6 |
7 |
9 |
21 |
| End Date |
2024-02-08 |
2023-11-07 |
2023-05-09 |
2022-05-09 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Martinez Maria D. |
Chief Human Resources Officer |
• – – |
2023-03-16 |
4 |
D |
$8.27 |
$35,313 |
D/D |
(4,270) |
29,308 |
|
- |
|
| Martinez Maria D. |
Chief Human Resources Officer |
• – – |
2023-03-16 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,517 |
30,898 |
|
- |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-02-01 |
4 |
AS |
$9.36 |
$136,188 |
D/D |
(14,550) |
61,945 |
|
-2% |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-02-01 |
4 |
OE |
$5.04 |
$105,538 |
D/D |
20,940 |
76,495 |
|
- |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-01-31 |
4 |
AS |
$9.55 |
$136,756 |
D/D |
(14,320) |
55,555 |
|
-2% |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-01-31 |
4 |
OE |
$5.04 |
$105,533 |
D/D |
20,939 |
69,875 |
|
- |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-01-30 |
4 |
AS |
$9.69 |
$136,736 |
D/D |
(14,111) |
48,936 |
|
-2% |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-01-30 |
4 |
OE |
$5.04 |
$105,533 |
D/D |
20,939 |
63,047 |
|
- |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-01-27 |
4 |
AS |
$10.16 |
$212,750 |
D/D |
(20,940) |
42,108 |
|
-8% |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-01-27 |
4 |
OE |
$5.04 |
$105,538 |
D/D |
20,940 |
63,048 |
|
- |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-01-26 |
4 |
AS |
$9.90 |
$207,296 |
D/D |
(20,939) |
42,108 |
|
-10% |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-01-26 |
4 |
OE |
$5.04 |
$105,533 |
D/D |
20,939 |
63,047 |
|
- |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-01-25 |
4 |
AS |
$10.23 |
$214,206 |
D/D |
(20,939) |
42,108 |
|
-16% |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2023-01-25 |
4 |
OE |
$5.04 |
$105,533 |
D/D |
20,939 |
63,047 |
|
- |
|
| Zaderej Karen L. |
CEO |
• • – |
2022-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,400 |
1,012,695 |
|
- |
|
| Scopelianos Angelo |
Chief R&D Officer |
• – – |
2022-12-27 |
4 |
D |
$9.44 |
$2,700 |
D/D |
(286) |
25,958 |
|
- |
|
| Scopelianos Angelo |
Chief R&D Officer |
• – – |
2022-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,150 |
26,244 |
|
- |
|
| Donovan Michael Patrick |
VP Operations |
• – – |
2022-12-27 |
4 |
D |
$9.44 |
$2,700 |
D/D |
(286) |
64,719 |
|
- |
|
| Donovan Michael Patrick |
VP Operations |
• – – |
2022-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,150 |
65,005 |
|
- |
|
| Devinney Erick Wayne |
VP Peripheral Nerve Science |
• – – |
2022-12-27 |
4 |
D |
$9.44 |
$1,765 |
D/D |
(187) |
106,531 |
|
- |
|
| Devinney Erick Wayne |
VP Peripheral Nerve Science |
• – – |
2022-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
750 |
106,718 |
|
- |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2022-12-27 |
4 |
D |
$9.44 |
$6,127 |
D/D |
(649) |
42,108 |
|
- |
|
| Mariani Peter J |
EVP & Chief Financial Officer |
• – – |
2022-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,625 |
42,757 |
|
- |
|
| Billet Isabelle |
Chief Strategy and BD Officer |
• – – |
2022-12-27 |
4 |
D |
$9.44 |
$3,087 |
D/D |
(327) |
25,065 |
|
- |
|
| Billet Isabelle |
Chief Strategy and BD Officer |
• – – |
2022-12-27 |
4 |
OE |
$0.00 |
$0 |
D/D |
1,150 |
25,392 |
|
- |
|
470 Records found
|
|
Page 3 of 19 |
|
|
0.11 (1.87%) 
